Cystic Fibrosis

Time To Read

12–18 minutes

Date Last Modified

Cell Membranes & Cell Transport · Case Study

Matilda’s Cells

Why a 19-year-old college student tastes salty when her parents kiss her forehead — and how the answer connects every patient you will ever care for to the same handful of molecular ideas.

What’s in this case study:

Matilda is 19. She’s a nursing student — just like you. She works part-time at a coffee shop near campus, lives in the dorms, and is starting to think about which clinical site she wants for next semester. To anyone glancing at her in the cafeteria, she looks like every other college freshman.

She is not, quite. Matilda has cystic fibrosis.

Cystic Fibrosis Foundation

Matilda’s story · the diagnosis

Why a kiss told her parents something was wrong

When Matilda was six weeks old, her mother kissed her forehead and noticed something strange: she tasted salt. Not a faint hint — distinct, like the rim of a margarita glass. She mentioned it to the pediatrician at the next well-baby visit. Her pediatrician already knew what that meant.

The doctor ordered a sweat chloride test. The result came back at 78 mEq/L. Normal is below 30. Anything above 60 confirms cystic fibrosis. Matilda’s parents had a diagnosis before she was three months old.

Every cell-biology concept you study is going to circle back to Matilda. You’ll learn about cell membranes by asking how hers are different. You’ll learn about osmosis by asking what happens to the thin layer of fluid sitting on top of her airway cells. You’ll learn about active transport by asking what’s broken in the protein channel that gives the disease its name.

By the end of this case study, you’ll be able to explain — at a molecular level — why a kiss on Matilda’s forehead tasted salty. And why every time she coughs, she is fighting a problem with osmosis.

Every cell in your body — every cell in Matilda’s body — is wrapped in a thin sheet of fat-and-protein called the plasma membrane. If you flattened one out and looked at its cross-section, you’d see two parallel rows of phospholipid molecules with their water-fearing tails pointing inward and their water-loving heads facing the watery fluids on either side. We call that arrangement the phospholipid bilayer.

This is not a wall. It’s a turnstile. Some things pass through easily; others can’t pass at all without help.

The phospholipid bilayer is hydrophobic in its middle — those greasy tails repel water. Small, uncharged molecules slip across without trouble (oxygen, carbon dioxide, water itself crosses slowly). Charged ions like sodium (Na⁺) and chloride (Cl⁻), on the other hand, are blocked. So are bigger molecules like glucose.

For those, the cell builds dedicated protein channels embedded in the bilayer. Each channel is selective: a chloride channel only carries chloride; a sodium channel only carries sodium. This selective permeability is the foundation of everything that follows in this case study.

A membrane that lets some substances through but blocks others. Cell membranes are semipermeable: water and small uncharged molecules cross easily; ions and most other solutes cross only through specific protein channels.

Why selective permeability matters at the bedside

When you administer a medication, its ability to cross cell membranes determines how it reaches its target. Lipid-soluble drugs cross easily. Water-soluble drugs often need to ride a transport protein. When you assess a patient’s electrolytes, you’re checking the ions that the membrane spent enormous energy keeping balanced. Selective permeability isn’t a textbook idea — it’s the reason your interventions work (or don’t).

Although water can push its way between the phospholipids, there are designated water channels called aquaporins. Many cells also have dedicated aquaporins for faster transit. What’s strange isn’t the fact that water moves. What’s strange is why it moves, and where it moves to.

Water moves down a concentration gradient — but it’s not its own concentration that matters. It’s the concentration of the stuff dissolved in it. Picture two cups separated by a membrane. The left cup has pure water; the right cup has water plus dissolved salt. Water will move from the left cup (lots of water, no solute) into the right cup (less water, lots of solute). It’s as if water is “pulled” toward the saltier side until both cups have the same proportion of dissolved stuff.

“Water moves across a semipermeable membrane from where the solute concentration is lower to where the solute concentration is higher — until the concentrations on both sides equalize.”

That movement of water across a semipermeable membrane is called osmosis. And it doesn’t require any energy from the cell. It happens passively, driven by the difference in solute concentration on either side of the membrane.

You’ll hear people describe osmosis two ways. Both are correct. The first is “water moves to the side with more solute.” The second is “water moves away from the side with more water.” They describe the same flow from opposite angles. Use whichever helps you predict the direction.

The net movement of water across a semipermeable membrane, from a region of lower solute concentration to a region of higher solute concentration. Passive — no ATP required.

Now we put it together. A cell is, at its simplest, a small bag of salty water (the cytoplasm) wrapped in a semipermeable membrane and floating in a larger bath of fluid (the extracellular space or, in the lab, a saline solution). When the solute concentration of the bath differs from the solute concentration inside the cell, water moves — and the cell changes shape.

To describe this comparison between the bath and the cell, we use three terms:

More concentrated than the cell interior. Water moves out of the cell. The cell shrinks. (Red blood cells in hypertonic solution become spiky — we call this crenation.)

Less concentrated than the cell interior. Water moves in to the cell. The cell swells. In extreme cases, the cell may burst — we call this lysis.

Equal concentration to the cell interior. No net water movement. The cell stays the same shape and size.

Red blood cells are the classic specimen for studying tonicity in introductory biology. They’re easy to obtain, they don’t have rigid cell walls, and they change shape dramatically when you change the saltiness around them. Look at the three images below.

HYPOTONIC
ECF

ISOTONIC
ECF

Cells swollen (or lysed)Red blood cells respond predictably to changes in extracellular tonicity. The membranes themselves don’t change — only the water inside the cells does.

Nursing relevance

IV fluid selection — it’s all tonicity

The bag of fluid you hang for a patient is chosen for its tonicity. 0.9% saline (normal saline) is roughly isotonic to plasma — safe for most uses. 3% saline (hypertonic) is reserved for specific conditions like severe hyponatremia and pulls water out of cells. 0.45% saline (hypotonic) is sometimes used to rehydrate cells, but cautiously, because too much can swell them dangerously. The bedside decision is osmosis.

So far we’ve talked about passive movement: diffusion of small molecules across the bilayer, osmosis of water down a concentration gradient. Neither requires the cell to spend energy. But cells often need to move things against their concentration gradient — pumping sodium out even when there’s more sodium outside, pumping potassium in even when there’s more potassium inside. That requires energy, in the form of ATP. We call this active transport.

Active transport is what lets your cells maintain steep concentration gradients that the membrane could never sustain on its own. And it’s where Matilda’s biology starts to diverge from yours.

The protein that cystic fibrosis is named for is called CFTR: cystic fibrosis transmembrane conductance regulator. It’s a chloride channel embedded in the membranes of epithelial cells — specifically, the cells that line your airways, your sweat ducts, your pancreas, your intestines, and a few other places. In a healthy person, CFTR opens (in response to specific signals) and lets chloride ions move out of the cell through it.

Illustration comparing cells in a healthy airway versus cells in the airway of someone with cystic fibrosis. The normal airway shows a clear inner passage. In the diagram of a healthy lung epithelial cell: chloride ions flow from the epithelial cell to the airway via the CFTR protein, water flows from the cell to lumen and is moved up, and sodium from the airway to the cell. The cystic fibrosis airway has thickened mucus. The diagram of a lung epithelial cell with cystic fibrosis; the chloride protein is blocked, sodium proteins are going from the airway to the cell and water is being drained from the airway.
Normal vs. cystic fibrosis airway cells. Shows healthy airways and CF airways with thickened mucus, impacting fluid balance.

Here’s the move that ties active transport to the osmosis you just learned: when CFTR pumps chloride out of the cell into the fluid on top of the cell, the solute concentration on top of the cell rises. And what does water do when solute concentration rises on one side of a membrane?

Water follows. That’s the whole trick.

CFTR doesn’t pump water directly. It pumps chloride. But by pumping chloride, it creates the concentration gradient that pulls water across the membrane by osmosis. CFTR is, in effect, a water-management system that works through chloride.

The mutation she inherited.

A Punnett square illustrates the possible genotypes and phenotypes resulting from a cross between two heterozygous individuals (Aa) for the CFTR gene. "A" represents a normally functioning CFTR allele, while "a" represents an abnormally functioning allele. The square shows that offspring can inherit AA (homozygous dominant, no disease), Aa (heterozygous, doesn't have the disease but can pass on) or aa (homozygous recessive, has the disease).
Punnett square showing heterozygote cross of CFTR alleles: AA (no disease), Aa (carrier), and aa (has disease).

Matilda inherited two copies of a mutated CFTR gene — one from each parent. (Her parents, who don’t have CF, each carry one mutated copy and one normal copy. With one normal copy, they make enough working CFTR to be healthy. Matilda doesn’t have that backup.) The specific mutation she carries, called ΔF508, is the most common one — it accounts for about 70% of CF cases worldwide.

ΔF508 causes the CFTR protein to misfold during its assembly. Misfolded CFTR proteins get tagged for destruction before they ever reach the cell membrane. So Matilda’s epithelial cells make CFTR — but the CFTR never arrives at the surface. Functionally, her airway cells have no working chloride channel.

To see what goes wrong in CF, picture a cross-section of a healthy airway. The wall of the airway is lined with a single layer of epithelial cells. On top of those cells sits a thin layer of watery fluid called the airway surface liquid, or ASL. On top of the ASL sits a thicker layer of mucus — sticky, gel-like, designed to trap inhaled dust and bacteria. And reaching up from the epithelial cells through the ASL and into the mucus are thousands of hair-like cilia, beating in coordinated waves to sweep the mucus (and everything stuck to it) up and out of the lungs.

Illustration of the trachea and lungs shows a cross-section of the trachea wall, which is made up of pseudostratified ciliated columnar epithelium. Cilia extend into the lumen. A zoomed-in portion of the wall shows how CFTR protein transports chloride ions, while another transporter moves sodium, to bring water into the mucus layer.
Trachea anatomy showing pseudostratified ciliated epithelium including CFTR protein function at the lung epithelial cell.

This whole system — called the mucociliary escalator — is the airway’s primary defense against infection. For it to work, three things have to be true. The mucus has to be the right thickness (thin enough to move). The ASL has to be deep enough to keep the cilia upright and free to beat. And the cilia have to be coordinated.

All three of those things depend on the ASL being hydrated. And keeping the ASL hydrated depends on healthy CFTR. Here is the cascade:

  1. Matilda’s CFTR is broken (misfolded, never reaches the membrane).
  2. Chloride ions stay trapped inside the airway epithelial cells — they can’t exit through the broken channel.
  3. No solute gradient forms across the apical membrane. The ASL above the cells has less solute than it should.
  4. Water does not follow. The osmotic pull that should hydrate the ASL is absent.
  5. The ASL becomes shallow and dehydrated. The mucus above it loses its water, too, becoming thick and sticky.
  6. The cilia get bogged down in the thickened mucus. They can’t beat properly. The mucociliary escalator stops moving.
  7. Bacteria — especially Pseudomonas aeruginosa — accumulate in the stagnant mucus and establish chronic infections.

This is why CF is, primarily, a lung disease. The lungs aren’t infected because of CFTR directly. The lungs are infected because CFTR’s failure breaks the osmosis that keeps the airway’s defenses moving.

“Every time Matilda coughs, she is fighting a problem with osmosis.”

A working mucus membrane with an inner layer of mucus with immunoglobulins and an outer layer with bacteria

The lungs are where CF does its worst damage. But the first sign of the disease — the sign that brought Matilda to her pediatrician at six weeks old — was a kiss. Her sweat was salty. To understand why, we have to look at one more piece of anatomy: the sweat duct.

Your sweat glands make sweat in two stages. First, secretory cells deep in the gland produce a watery, salty fluid that flows up the duct toward the skin surface. Then, as that fluid travels up the duct, the cells lining the duct reabsorb sodium and chloride back into the body. By the time the fluid reaches the skin, most of the salt has been recovered. The sweat that comes out is mostly water, with just a trace of salt.

This reabsorption step is the one that requires CFTR. In a healthy duct, CFTR carries chloride from the duct fluid back into the cells lining the duct (and sodium follows, drawn by the negative chloride). Without functional CFTR, the chloride can’t be pulled back. It stays in the duct. The sodium stays too. The sweat that reaches the skin carries the full salt load that was supposed to be reabsorbed.

What 78 mEq/L actually means

The sweat chloride test that diagnosed Matilda at six weeks old measures exactly this: how much chloride is in her sweat once it reaches the skin. In a healthy person, less than 30 mEq of chloride remains per liter of sweat. In CF, the number climbs above 60. Matilda’s result was 78 mEq/L. The number itself was the diagnosis.

The sweat test is still considered the gold standard for diagnosing cystic fibrosis. Even with genetic testing widely available, the sweat chloride test is the confirmatory test that pediatric pulmonologists order. It’s been used for diagnosis since 1959.

Skin findings can be diagnostic clues

The salty-skin observation in CF is a useful reminder of a broader nursing principle: the body’s surface reveals what’s happening underneath. A patient whose skin tastes salty (in infants, this is a real and validated parent observation) deserves a sweat chloride workup. A patient with poor skin turgor is showing you osmosis in real time. Train yourself to notice the surface.

Matilda’s daily routine is shaped by her CFTR. She wakes up about an hour earlier than her roommate does. The first thirty minutes of every day go to airway clearance — physical maneuvers (a vibrating vest, postural drainage, or specific breathing exercises) designed to help her loosen and cough up the mucus her cilia can’t move. She nebulizes hypertonic saline, which uses osmosis on purpose: by making the airway fluid temporarily saltier, it pulls water from her airway cells into the ASL, thinning the mucus enough to clear it.

She takes pancreatic enzymes with every meal — her pancreas, like her airways, has CFTR-lined ducts that have been damaged by the same mechanism, so it doesn’t release digestive enzymes properly. And like an increasing number of CF patients, she takes a CFTR modulator — a class of newer drugs (most prominently Trikafta) that, in patients with the ΔF508 mutation, can actually rescue some of the misfolded protein and get it to the cell surface where it can do its job. CFTR modulators have transformed CF care over the past decade.

As a nurse, you may meet Matilda — or someone like her — in many settings. In a primary care clinic during a routine visit. In a hospital during an acute exacerbation when her chronic infection flares. In a pulmonary clinic for her quarterly check-up. In an emergency department if she’s having trouble breathing. In an OB unit one day, perhaps; CF patients today routinely reach reproductive age, and women with CF do become pregnant.

Every encounter requires you to remember that what’s happening in her airways — and in her sweat, and in her pancreas — comes back to the same molecular failure. Her care is built on osmosis. Her therapies leverage osmosis. The hypertonic saline you might administer at the bedside is osmosis. The IV fluids you select must respect her unique fluid balance. The medications she takes intersect with the same cellular machinery you studied today.

What Matilda would want you to know

Patients with CF have spent their entire lives learning their disease. They are, in many cases, more expert in their own physiology than the nurses who care for them. Treat them as partners. Ask before assuming. The most useful question you can ask a CF patient at admission is not “Do you have CF?” — it’s “What does your routine look like at home, and what do you need from me to keep it going?”

List of terms